These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 30796300)
41. Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences. Shobeiri N; Pang J; Adams MA; Holden RM J Hypertens; 2013 Jan; 31(1):160-8. PubMed ID: 23183279 [TBL] [Abstract][Full Text] [Related]
42. Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism. McCabe KM; Zelt JG; Kaufmann M; Laverty K; Ward E; Barron H; Jones G; Adams MA; Holden RM J Pharmacol Exp Ther; 2018 Sep; 366(3):433-445. PubMed ID: 29903718 [TBL] [Abstract][Full Text] [Related]
43. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats. Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070 [TBL] [Abstract][Full Text] [Related]
44. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease. Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675 [TBL] [Abstract][Full Text] [Related]
45. Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKD. Zelt JG; Svajger BA; Quinn K; Turner ME; Laverty KJ; Shum B; Holden RM; Adams MA J Bone Miner Res; 2019 Feb; 34(2):270-281. PubMed ID: 30216554 [TBL] [Abstract][Full Text] [Related]
46. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification. Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101 [TBL] [Abstract][Full Text] [Related]
47. Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease. Yang X; Liu Y; Zhu X; Chen P; Xie X; Xu T; Zhang X; Zhao Y Ren Fail; 2023 Dec; 45(1):2228920. PubMed ID: 37369635 [TBL] [Abstract][Full Text] [Related]
48. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289 [TBL] [Abstract][Full Text] [Related]
50. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification. Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065 [TBL] [Abstract][Full Text] [Related]
51. Exogenous BMP7 administration attenuated vascular calcification and improved bone disorders in chronic uremic rats. Lee CT; Kuo WH; Tain YL; Wang Y; Lee WC Biochem Biophys Res Commun; 2022 Sep; 621():8-13. PubMed ID: 35809346 [TBL] [Abstract][Full Text] [Related]
52. Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice. Wang X; Parasaram V; Dhital S; Nosoudi N; Hasanain S; Lane BA; Lessner SM; Eberth JF; Vyavahare NR Sci Rep; 2021 Apr; 11(1):8584. PubMed ID: 33883612 [TBL] [Abstract][Full Text] [Related]
53. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease. Han X; Wang LY; Diao ZL; Liu WH Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047 [TBL] [Abstract][Full Text] [Related]
55. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression. Kim JH; Choi YK; Do JY; Choi YK; Ha CM; Lee SJ; Jeon JH; Lee WK; Choi HS; Park KG; Lee IK Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2384-90. PubMed ID: 26404484 [TBL] [Abstract][Full Text] [Related]
56. Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment. O'Brien SF; Kelly SE; Dolphin PJ; Russell JC Clin Invest Med; 2000 Apr; 23(2):124-31. PubMed ID: 10852662 [TBL] [Abstract][Full Text] [Related]
57. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification. Chao CT; Liu YP; Su SF; Yeh HY; Chen HY; Lee PJ; Chen WJ; Lee YM; Huang JW; Chiang CK; Hung KY; Chen HW Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1402-1414. PubMed ID: 28522697 [TBL] [Abstract][Full Text] [Related]
58. Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Henze LA; Luong TTD; Boehme B; Masyout J; Schneider MP; Brachs S; Lang F; Pieske B; Pasch A; Eckardt KU; Voelkl J; Alesutan I Aging (Albany NY); 2019 Aug; 11(15):5445-5462. PubMed ID: 31377747 [TBL] [Abstract][Full Text] [Related]